Leiden

• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 4 Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl … Not authorised
  2022-501006-34-00 5 Liver cirrhosis
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Not authorised
  2024-514693-47-00 11 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• A study to find how well LY3884961 works and how safe it is in participants with Parkinson’s disease Not authorised
  2024-519587-40-00 7 Parkinson’s Disease with at Least One GBA1 Mutation
• RATE: Reduced anticoagulation targets in extracorporeal life support Pending
  2023-509675-16-01 5 All patients who receive ECMO treatment during the study period in one
• An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants with Duchenne Muscular Dystrophy Pending
  2024-511656-41-00 4 Duchenne Muscular Dystrophy
• Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco … Pending
  2024-512850-10-00 5 Resectable colorectal rectal metastases without extrahepatic disease
• Avelumab Short Maintenance Trial Pending
  2024-512975-11-01 11 urothelial cancer
• Investigating the (autoreactive) B cell compartment in antibody-mediated autoimmune diseases in comparison with the recall Tetanus Toxoid re … Pending
  2024-515312-50-00 6 Systemic sclerosis
• A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease Pending
  2024-517310-15-00 3 Parkinson's Disease
• RESET-TRD; a Randomised trial on oral ESketamine compared to Electroconvulsive Therapy for patients with Treatment Resistant Depression Pending
  2024-517485-42-00 5 Non-psychotic therapy resistant unipolar depression
• Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients Pending
  2024-517939-53-00 1 Respiratory tract diseases
• A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel … Pending
  2024-519786-22-01 9 metastatic non-small cell lung cancer (NSCLC)
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• A phase III trial of a De-escalated Immune-strategy During first-line treAtment in patients with metastatic non-small Cell lung cancer (NSCL … Pending
  2025-520792-67-00 5 Patients with advanced, metastatic NSCLC that have not progressed on a
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• A Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis. Pending
  2025-522373-10-00 5 Progressive pulmonary fibrosis and Idiopathic pulmonary fibrosis
• OVACURE-2 Pending
  2025-522659-24-00 9 Ovarian carcinoma
• A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy Pending
  2025-522949-22-00 5 Duchenne muscular dystrophy
• Osteogenesis Imperfecta Trial of AGA2115 for ADUlts with COL1A1 and/or COL1A2 GeNetic Variations (IDUN) Pending
  2025-522951-24-00 4 Osteogenesis Imperfecta
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of In … Pending
  2025-523087-20-00 5 Duchenne muscular dystrophy
• Cangrelor safety and pharmacodynamics in paediatric subjects with congenital heart disease Pending
  2025-523109-14-00 5 Congenital Heart Disease
• A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis Pending
  2025-523127-21-00 3 Rheumatoid Arthritis
• PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer Pending
  2025-523134-28-00 10 ABC borderline resectable pancreatic cancer

Showing 1–24 of 459 trials